HPM Partners »

Vanda Pharmaceuticals shares owned by HPM Partners

Quarter-by-quarter ownership of Vanda Pharmaceuticals (VNDA) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Vanda Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Vanda Pharmaceuticals held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vanda Pharmaceuticals by HPM Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $155k 31k 4.99
2025-06-30 $69k 15k 4.72

More positions owned by HPM Partners

Vanguard Index Fds Etf (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corp Stock (MSFT)
iShares S&P 500 Index (IVV)
Spdr S&p 500 Etf (SPY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Etf (IEFA)
Amazon Stock (AMZN)
Broadcom (AVGO)
Procter & Gamble Company (PG)
Alphabet Stock (GOOGL)
Alphabet Stock (GOOG)
Ishares Tr Etf (QUAL)
Meta Platforms Stock (META)

View all positions for HPM Partners

Top funds holding Vanda Pharmaceuticals

BlackRock
Vanguard Group
Renaissance Technologies
Millennium Management
Dimensional Fund Advisors
Tang Capital Management
Acadian Asset Management
Geode Capital Management
State Street Corporation
Krensavage Asset Management
Two Sigma Advisers
Connor, Clark & Lunn Investment Management
Morgan Stanley
Empire Financial Management Company
Federated Investors

View all funds holding Vanda Pharmaceuticals